Origin and In-Office Treatment of Retrograde Cricopharyngeus Dysfunction

咽喉反流 医学 回流 病史 家族史 疾病 内科学 儿科
作者
Marie Mailly,Robin Baudouin,Camille Thibault,Stéphane Hans,Jérôme R. Lechien
出处
期刊:JAMA otolaryngology-- head & neck surgery [American Medical Association]
卷期号:151 (4): 396-396 被引量:7
标识
DOI:10.1001/jamaoto.2024.5046
摘要

Importance Retrograde cricopharyngeus dysfunction (R-CPD) is an emerging disorder associated with disabling symptoms. The origin of R-CPD remains unknown. Objective To investigate the development of symptoms, diagnosis approach, and therapeutic outcomes of R-CPD in patients treated with in-office botulinum toxin injection (BTI) into the cricopharyngeus. Design, Setting, and Participants This was a case series including patients with R-CPD who were consecutively and prospectively recruited from April 2022 to May 2024 in an academic hospital. Semistructured interviews were conducted to collect and analyze data on each patient’s clinical history, potential causes or factors associated with R-CPD development, diagnostic approaches, and symptom presentation. Intervention Clinic-based (in-office) BTI into the cricopharyngeus. Outcomes and Measures Associations with laryngopharyngeal reflux disease, patients’ Reflux Symptom Score-12 (RSS-12), and BTI effectiveness, revisions, and complications were evaluated. Results The case series comprised 106 patients with R-CPD treated with BTI (52 females [49.1%] and 54 males [51.9%]). Their mean (SD) age at symptom onset was 13.6 (7.7) years, and at diagnosis, 30.4 (6.4) years. Sixty-eight patients (64.2%) had potential congenital R-CPD, according to the parents’ testimonies. A family history was reported in 18 of 62 cases (29.0%). In 105 cases (99.1%), patients made the diagnosis themselves despite medical consultations (n = 162), empirical treatments (n = 113), and additional examinations (n = 92). The cumulative success rate of BTI was 90.6% (96 of 106 patients). In 26 cases (24.5%), additional injections were administered to address the symptoms. Family history of R-CPD was a negative predictor of single-BTI success. Dysphagia was the primary adverse effect occurring after 89 of 126 BTIs (70.6%) and lasted a mean (SD) of 16.3 (12.0) days. In 10 cases, operating-room BTI was administered after primary in-office BTI. Conclusions and Relevance R-CPD is an emerging and poorly known disorder associated with high rates of ineffective consultations, additional examinations, and self-diagnosis by patients. In-office BTI was associated with a high rate of partial or total symptom relief and long-term effectiveness.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SciGPT应助科研通管家采纳,获得10
刚刚
大模型应助科研通管家采纳,获得10
刚刚
小丽应助科研通管家采纳,获得10
刚刚
情怀应助科研通管家采纳,获得10
刚刚
Kelly完成签到,获得积分10
2秒前
姜伟完成签到,获得积分10
2秒前
Yao完成签到,获得积分10
2秒前
坚定的小蘑菇完成签到 ,获得积分10
3秒前
ccx完成签到,获得积分10
3秒前
小曹医生完成签到,获得积分10
9秒前
HuC完成签到,获得积分20
9秒前
li完成签到,获得积分10
10秒前
完犊子完成签到,获得积分10
11秒前
11秒前
空龙完成签到,获得积分10
12秒前
矮小的安柏完成签到,获得积分10
12秒前
川川完成签到 ,获得积分10
12秒前
Dragon完成签到,获得积分10
12秒前
杨胜菲完成签到,获得积分10
13秒前
小李老博完成签到,获得积分10
14秒前
Junwen完成签到,获得积分10
15秒前
小鹿呀完成签到,获得积分10
15秒前
发发旦旦完成签到,获得积分10
16秒前
16秒前
微雨若,,完成签到 ,获得积分10
16秒前
PDIF-CN2完成签到,获得积分10
17秒前
学生信的大叔完成签到,获得积分10
18秒前
蔡从安完成签到,获得积分20
20秒前
栗子完成签到,获得积分10
20秒前
韭菜完成签到,获得积分10
20秒前
倒立才能看文献完成签到 ,获得积分10
21秒前
老朱完成签到,获得积分10
22秒前
茅十八完成签到,获得积分10
23秒前
蛋花肉圆汤完成签到,获得积分0
24秒前
毅然决然必然完成签到,获得积分10
24秒前
25秒前
徐晚疯完成签到,获得积分10
26秒前
橙神完成签到,获得积分10
26秒前
YQQ完成签到,获得积分10
26秒前
顾守完成签到,获得积分10
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to Helicopter and Tiltrotor Flight Simulation, Second Edition 2500
卤化钙钛矿人工突触的研究 2000
Malcolm Fraser : a biography 700
Signals, Systems, and Signal Processing 610
Software that combines deep learning,3D reconstruction and CFD to analyze the state of carotid arteries from ultrasound imaging 600
Bounds for Statistical Estimation in Semiparametric Models 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6498137
求助须知:如何正确求助?哪些是违规求助? 8294136
关于积分的说明 17696842
捐赠科研通 5594091
什么是DOI,文献DOI怎么找? 2917588
邀请新用户注册赠送积分活动 1894530
关于科研通互助平台的介绍 1755120